Factors Influencing Adverse Drug Reaction Reporting in New South Wales Teaching Hospitals

Journal of Pharmacy Practice and Research

Volumn 34, Issue 1, 2004, Pages 32-35

  Kelly, Maria ^a   Kaye, Karen I ^c   Davis, Sharon R ^a   Shenfield, Gillian M ^b  

^a NSW Therapeut Advsy Grp   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

^c NSW Therapeut Advsy Grp ^*

Author keywords

[No Author keywords available]

Indexed keywords

UNCLASSIFIED DRUG;

ARTICLE; AUSTRALIA; AWARENESS; COMPUTER ANALYSIS; DISEASE PREDISPOSITION; DRUG INDUCED DISEASE; HEALTH PROMOTION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; NURSE; PARAMEDICAL PERSONNEL; PATIENT ATTITUDE; PHARMACIST; PHYSICAL DISABILITY; PHYSICIAN; QUESTIONNAIRE; RISK ASSESSMENT; SIDE EFFECT; TEACHING HOSPITAL;

EID: 1942537539     PISSN: 1445937X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jppr200434132     Document Type: Article

References (15)

1. National Pharmacovigilance Systems. 2nd ed. Uppsala: WHO Collaborating Centre for International Drug Monitoring; 1999.
2. Rogers AS, Israel E, Smith CR, Levine D, McBean AM, Valente C, et al. Physician knowledge, attitudes, and behavior related to reporting adverse drug events. Arch Intern Med 1988; 148: 1596-600.
3. Lumley CE, Walker SR, Hall GC, Staunton N, Grob PR. The under-reporting of adverse drug reactions seen in general practice. Pharmaceut Med 1986; 1: 205-12.
4. Atkin PA, Finnegan TP, Ogle SJ, Talmont DM, Shenfield GM. Prevalence of drug related admissions to a hospital geriatric service. Aust J Ageing 1994; 13: 17-21.
5. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200-5.
6. Roughead EE, Gilbert AL, Primrose JG, Sansom LN. Coding drug-related admissions in medical records: is it adequate for monitoring the quality of medication use? Aust J Hosp Pharm 1998; 28: 7-12.
7. McGettigan P, Golden J, Conroy RM, Arthur N, Feely J. Reporting of adverse drug reactions by hospital doctors and the response to intervention. Br J Clin Pharmacol 1997; 44: 98-100.
8. Hawe P, Degeling D, Hall J. Evaluating health promotion. Sydney: MacLennan and Petty; 1990. p. 254.
9. Belton KJ, Lewis SC, Paynes S, Rawlins MD, Wood SM. Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom. Br J Clin Pharmacol 1995; 39: 223-6.
10. Wing LM. Adverse drug reaction reporting-knowledge and attitudes of hospital doctors. Proc Aust Soc Clin Exp Pharmacol Toxicol 1995; 2.
11. McGettigan P. Feely J. Adverse drug reaction reporting: opinions and attitudes of medical practitioners in Ireland. Pharmacoepidemiol Drug Saf 1995; 4: 355-8.
12. Generali JA, Danish MA, Rosenbaum SE. Knowledge of and attitudes about adverse drug reaction reporting among Rhode Island pharmacists. Ann Pharmacother 1995; 29: 365-9.
13. Belton KJ. Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union. Eur J Clin Pharmacol 1997; 52: 423-7.
14. Green CF, Mottram DR, Brown AM, Rowe PH. Attitudes of hospital pharmacists to adverse drug reactions and the yellow card scheme: a qualitative study. Int J Pharm Pract 1999; 7: 247-55.
15. Shenfield GM, Robb T, Duguid M. Recording previous adverse drug reactions -a gap in the system. Br J Clin Pharmacol 2001; 51: 623-6.